At a Glance
  • Status: Active Consortium
  • Year Launched: 2012
  • Initiating Organization: European Commission Seventh Framework Programme (FP7)
  • Initiator Type: Government
  • Disease focus:
    Acute/Chronic Infectious Disease
  • Location: Europe

Abstract

Infect-ERA is an ERA-NET on human infectious diseases funded under the Seventh Research Framework Programme (2013-2016). To date, it is a consortium of 14 partners from 11 countries. It is a continuation of the ERA-NET PathoGenoMics.

Mission

Infectious diseases (ID), also known as communicable diseases, cause tens of thousands of deaths each year in Europe. Despite all the measures taken to address the ID, different factors have contributed to the more recent ID challenges: (a) the threat of emerging ID (16 new and five reemerging IDs were identified in the past two decades, (b) mass migration, global travelers, and growth of congested urban slums, (c) misuse and overuse of antibiotics, and (c) co-infection with at least two pathogens. Hence, continuous global effort and novel avenues of research are required to decipher the role of the new factors in the development of ID.

Through this initiative, Infect-ERA partners aim to understand all basic aspects of complex human infection biology questions such as co-infection that are not limited to specific pathogens, the cross-talk between host and pathogens, as well as the relationship between microbes’ environment and infection. Infect-ERA plans to launch four yearly Join Transnational Calls (2013-2016) in order to fund high-quality and cutting-edge translational research bringing together basic, applied, technology-driven, and clinical research approaches to a broad variety of topics regarding human infectious diseases.

Infect-ERA will also develop a long-term cooperation framework in ID, contribute to the European mobility initiatives, strengthen the European research by expanding support to young scientists, and enable further knowledge on intellectual property protection among European scientists.

Structure & Governance

The Infect-ERA ERA-NET management structure is composed of five interacting entities:

Financing

Infect-ERA is funded by the European Commission’s Seventh Framework Programme (FP7). 

Infect-ERA provides information for researchers who are looking for collaborators, funding opportunities, infrastructure information, future conferences, and training. At the start of 2015, eight proposals were selected for funding:

Homepage

http://www.infect-era.eu/

Facebook

https://www.facebook.com/pages/Infect-ERA/429544013792924

LinkedIn

https://www.linkedin.com/grp/home?gid=4995046

Points of Contact

infect-eracoord@agencerecherche.fr
Infect-ERA Coordinator
Health and Biology Department
Agence Nationale de la Recherche (ANR)
50, avenue Daumesnil
75012 Paris (France)
phone: +33 1 73 54 81 40

Sponsors & Partners

Agence National Recherche (ANR)

Agency for Innovation by Science and Technology (IWT-Flanders)

Australian Science Fund (FWF)

Chief Scientist Office, Israeli Ministry of Health

Fundaçãopara a Ciência e a Tecnologia (FCT)

Hungarian Academy of Sciences

InnovationsFonden

Instituto de Salud Carlos III (ISCIII)

Ministerul Educaţiei Naţionale (MEN)

Ministry of Economy and Competitiveness (MINECO)

National Science Centre, Poland (NCN)

Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)

Projekttrager Julich Forschungszentrum Julich (Project Management Julich)

The National Centre for Research and Development, Poland ((NCBIR)


Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.